Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CHE
CHE logo

CHE Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
375.390
Open
371.000
VWAP
372.59
Vol
276.28K
Mkt Cap
5.15B
Low
368.490
Amount
102.94M
EV/EBITDA(TTM)
12.12
Total Shares
13.77M
EV
5.08B
EV/OCF(TTM)
13.09
P/S(TTM)
2.14
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
Show More

Events Timeline

(ET)
2026-02-25
17:00:00
Q4 Revenue at $639.3M, Below Consensus of $659.09M
select
2026-02-25
17:00:00
VITAS 2026 Revenue Expected to Increase 5.5%-6.5%
select
2026-02-13 (ET)
2026-02-13
13:30:00
Chemed Corporation Authorizes Additional $300M Stock Repurchase
select

News

NASDAQ.COM
4.5
02-27NASDAQ.COM
US Stocks Close Mixed: Dow Rises Slightly, Nasdaq Declines
  • Mixed Market Performance: On Thursday, the S&P 500 Index fell by 0.54% and the Nasdaq 100 Index declined by 1.16%, while the Dow Jones Industrial Average rose slightly by 0.03%, indicating a divergence in market sentiment, particularly under pressure from tech stocks.
  • Nvidia Earnings Impact: Nvidia reported Q4 revenue of $62.3 billion, exceeding expectations, yet its stock dropped over 5% due to uncertainties regarding the Chinese market, reflecting investor concerns about an overheated AI economy that could affect related chipmakers' performance.
  • Labor Market Signals: Initial jobless claims in the US rose by 4,000 to 212,000, lower than the expected 216,000, indicating resilience in the labor market, which may provide support for the stock market, especially amid potential interest rate cuts by the Fed.
  • Geopolitical Risks Intensify: President Trump threatened military action against Iran, heightening market uncertainty; although there are signs of progress in US-Iran nuclear negotiations, geopolitical risks remain a focal point for investors and could negatively impact the stock market.
Globenewswire
7.0
02-26Globenewswire
Investigation into Chemed Corporation Investor Claims
  • Earnings Miss: Chemed Corporation reported its Q4 2025 financial results on February 26, 2026, revealing adjusted earnings per share of $6.42 and revenue of $639.3 million, which fell short of consensus estimates by approximately $0.61 and $19.8 million, indicating potential profitability challenges that could undermine investor confidence going forward.
  • Stock Price Decline: Following the earnings report, Chemed's shares experienced a decline on February 26, 2026, as investor concerns about the company's future performance intensified, potentially prompting more investors to seek legal recourse to recover their losses.
  • Legal Investigation Initiated: Johnson Fistel, PLLP is investigating whether Chemed's executives violated federal securities laws, and if findings indicate wrongdoing, the company may face increased legal liabilities and financial repercussions.
  • Investor Rights Protection: Johnson Fistel, PLLP, a recognized shareholder rights law firm, has successfully recovered approximately $90.725 million for clients, demonstrating its effectiveness in advocating for investor rights, which may encourage more affected investors to participate in claims.
seekingalpha
9.5
02-26seekingalpha
Chemed Corporation Q4 2025 Earnings Call Insights
  • VITAS Admissions Growth: In Q4 2025, VITAS admissions reached 17,419, marking a 6% increase from the same period in 2024, indicating positive progress in patient recruitment that is expected to lay the groundwork for future revenue growth.
  • Financial Performance Overview: VITAS reported net revenue of $418.8 million in Q4 2025, a 1.9% year-over-year increase, but adjusted EBITDA was $91.6 million, down 1.7% year-over-year, highlighting challenges in balancing cost control with revenue growth.
  • Roto-Rooter Revenue Decline: Roto-Rooter experienced a 3.7% revenue decline in Q4 2025, despite a 1.6% increase in commercial revenue, with residential revenue down 3.1%, reflecting the impact of intensified market competition and fluctuating service demand.
  • Future Outlook and Strategy: Management anticipates 2026 will be a transition year, with VITAS revenue projected to grow by 5.5% to 6.5%, while Roto-Rooter is expected to achieve revenue growth of 3% to 3.5%, demonstrating the company's confidence in restoring growth moving forward.
seekingalpha
9.5
02-26seekingalpha
Chemed Shares Hit 52-Week Low After Q4 Earnings Miss
  • Disappointing Earnings: Chemed reported Q4 2025 financials with adjusted EPS of $6.42 and revenue of $639.3 million, missing consensus estimates by $0.61 and $19.8 million, indicating pressure on the company's profitability.
  • Decline in Roto-Rooter Segment: The Roto-Rooter segment saw a ~4% year-over-year revenue drop to $220.6 million, reflecting ongoing challenges in plumbing and cleaning services in both U.S. and international markets, impacting overall performance.
  • Analyst Downgrade: Bank of America downgraded Chemed from Buy to Neutral and lowered the price target from $595 to $450, primarily due to Roto-Rooter's EBITDA contracting for three consecutive years, leading to cautious expectations for 2026 guidance.
  • Stable Growth in Vitas Segment: Despite challenges in Roto-Rooter, the Vitas segment achieved approximately 2% year-over-year growth, reaching $418.8 million, with analysts suggesting its relatively stable growth could offset the weaknesses in Roto-Rooter.
NASDAQ.COM
4.5
02-26NASDAQ.COM
US Stocks Mostly Lower as Nvidia Earnings Fail to Boost Market Sentiment
  • Market Weakness: The S&P 500 index fell by 0.74% and the Nasdaq 100 index dropped by 1.40%, indicating market concerns over Nvidia's earnings failing to alleviate worries about an overheated AI economy, which pressured chipmakers and AI infrastructure stocks.
  • Nvidia Earnings Impact: Despite Nvidia reporting Q4 revenue of $62.3 billion, surpassing the consensus of $60.36 billion, its stock declined over 4% due to concerns regarding the Chinese market, reflecting investor doubts about demand durability.
  • Salesforce Strong Performance: Salesforce shares rose more than 3%, leading software stocks higher after it provided a strong long-term sales outlook and announced a large share buyback, alleviating fears of AI disruption in the software sector.
  • Geopolitical Risks Intensify: Ongoing nuclear talks between the US and Iran have heightened geopolitical risks, with President Trump threatening military action against Iran, which has further impacted investor sentiment and market stability.
NASDAQ.COM
4.5
02-26NASDAQ.COM
Mixed U.S. Stock Market as Nvidia Earnings Fail to Boost Investor Confidence
  • Mixed Market Performance: The S&P 500 Index is down 0.35% while the Dow Jones Industrial Average is up 0.29%, indicating a divergence in market sentiment, particularly after Nvidia's earnings failed to alleviate concerns about an overheated AI economy, putting pressure on chipmakers and AI infrastructure stocks.
  • Nvidia Earnings Reaction: Nvidia reported Q4 revenue of $62.3 billion, exceeding the consensus of $60.36 billion; however, its stock fell over 3% due to ongoing uncertainties regarding the Chinese market, reflecting investor concerns about demand durability.
  • Support from Job Data: Initial jobless claims in the U.S. rose by 4,000 to 212,000, which was better than the expected 216,000, indicating labor market strength and potentially providing some support for the stock market amidst mixed signals.
  • Geopolitical Risks: As nuclear talks between the U.S. and Iran progress, President Trump has threatened limited military action against Iran, heightening market uncertainty, although easing geopolitical tensions have provided some temporary relief to stocks.
Wall Street analysts forecast CHE stock price to rise
3 Analyst Rating
Wall Street analysts forecast CHE stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
475.00
Averages
547.33
High
595.00
Current: 0.000
sliders
Low
475.00
Averages
547.33
High
595.00
Oppenheimer
Michael Wiederhorn
Outperform
to
NULL
downgrade
$580 -> $500
AI Analysis
2026-02-27
Reason
Oppenheimer
Michael Wiederhorn
Price Target
$580 -> $500
AI Analysis
2026-02-27
downgrade
Outperform
to
NULL
Reason
Oppenheimer analyst Michael Wiederhorn lowered the firm's price target on Chemed to $500 from $580 and keeps an Outperform rating on the shares. The firm notes Chemed reported a Q4 miss, with one-third due to Vitas and two-thirds due to Roto-Rooter. However, Vitas has already created cap buffer in Florida, and is currently working through the related mix-pressures. While Oppenheimer sees long-term value creation opportunity in the consolidated portfolio following this earnings/outlook/pullback, but argues that, if necessary, there is an opportunity to unlock value by breaking up the company.
RBC Capital
Outperform -> Sector Perform
downgrade
$572 -> $422
2026-02-27
Reason
RBC Capital
Price Target
$572 -> $422
2026-02-27
downgrade
Outperform -> Sector Perform
Reason
RBC Capital downgraded Chemed to Sector Perform from Outperform with a price target of $422, down from $572. The firm cites near and longer-term Roto-Rooter margin uncertainty for the downgrade, but it remains "encouraged" by Vitas' momentum, particularly within Florida. Headwinds impacting Roto-Rooter may begin to "mask value" in the Vitas unit as the hospice segment rebalances mix over the course of the year, potentially heightening investor interest in a separation transaction, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CHE
Unlock Now

Valuation Metrics

The current forward P/E ratio for Chemed Corp (CHE.N) is 16.91, compared to its 5-year average forward P/E of 23.78. For a more detailed relative valuation and DCF analysis to assess Chemed Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
23.78
Current PE
16.91
Overvalued PE
26.22
Undervalued PE
21.33

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
16.07
Current EV/EBITDA
11.60
Overvalued EV/EBITDA
17.61
Undervalued EV/EBITDA
14.54

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.30
Current PS
2.25
Overvalued PS
3.66
Undervalued PS
2.94

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

current bullish rsi divergences
Intellectia · 213 candidates
Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
NVO logo
NVO
Novo Nordisk A/S
170.38B
MELI logo
MELI
MercadoLibre Inc
89.62B
NTES logo
NTES
NetEase Inc
73.21B
ET logo
ET
Energy Transfer LP
63.96B
BIDU logo
BIDU
Baidu Inc
45.60B
TCOM logo
TCOM
Trip.com Group Ltd
35.00B
for a binnger
Intellectia · 22 candidates
Beta: LowRiskDebt Equity: <= 1Weekly Average Turnover: >= 1,000,000Annual Eps Yoy Growth: >= 0.0%Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TW logo
TW
Tradeweb Markets Inc
24.53B
ERIE logo
ERIE
Erie Indemnity Co
14.64B
JKHY logo
JKHY
Jack Henry & Associates Inc
13.59B
DT logo
DT
Dynatrace Inc
11.88B
EPAM logo
EPAM
Epam Systems Inc
11.76B
NYT logo
NYT
New York Times Co
11.51B

Whales Holding CHE

C
Copeland Capital Management, LLC
Holding
CHE
+6.51%
3M Return
V
Van Berkom and Associates Inc.
Holding
CHE
+0.43%
3M Return
S
Schwartz Investment Counsel, Inc.
Holding
CHE
-2.26%
3M Return
A
Aptus Capital Advisors, LLC
Holding
CHE
-7.27%
3M Return
I
Integrated Wealth Concepts LLC
Holding
CHE
-8.81%
3M Return
B
Bridges Investment Management Inc
Holding
CHE
-9.53%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Chemed Corp (CHE) stock price today?

The current price of CHE is 373.89 USD — it has increased 0.13

What is Chemed Corp (CHE)'s business?

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

What is the price predicton of CHE Stock?

Wall Street analysts forecast CHE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHE is547.33 USD with a low forecast of 475.00 USD and a high forecast of 595.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Chemed Corp (CHE)'s revenue for the last quarter?

Chemed Corp revenue for the last quarter amounts to 639.34M USD, decreased -0.10

What is Chemed Corp (CHE)'s earnings per share (EPS) for the last quarter?

Chemed Corp. EPS for the last quarter amounts to 5.49 USD, decreased -8.96

How many employees does Chemed Corp (CHE). have?

Chemed Corp (CHE) has 15811 emplpoyees as of March 25 2026.

What is Chemed Corp (CHE) market cap?

Today CHE has the market capitalization of 5.15B USD.